Lars Michel

1.6k total citations
46 papers, 864 citations indexed

About

Lars Michel is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lars Michel has authored 46 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 24 papers in Cardiology and Cardiovascular Medicine and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lars Michel's work include Cancer Immunotherapy and Biomarkers (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (12 papers) and Cardiac Imaging and Diagnostics (7 papers). Lars Michel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (12 papers) and Cardiac Imaging and Diagnostics (7 papers). Lars Michel collaborates with scholars based in Germany, Hungary and United States. Lars Michel's co-authors include Tienush Rassaf, Matthias Totzeck, Raluca Mincu, Amir A. Mahabadi, Fadi Al‐Rashid, Simone M. Mrotzek, Stephan Settelmeier, Dirk Schadendorf, Yi Lin and Joerg Herrmann and has published in prestigious journals such as Nature Communications, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Lars Michel

41 papers receiving 852 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Michel Germany 13 456 373 188 146 126 46 864
Carrie G. Lenneman United States 8 363 0.8× 176 0.5× 122 0.6× 76 0.5× 100 0.8× 18 526
Nesreen S. Ismail United States 10 611 1.3× 459 1.2× 598 3.2× 91 0.6× 299 2.4× 19 1.4k
Christopher Kane United States 13 295 0.6× 85 0.2× 258 1.4× 87 0.6× 149 1.2× 23 802
Denise Traxler Austria 16 257 0.6× 141 0.4× 379 2.0× 32 0.2× 92 0.7× 56 821
Takahiro Nishida Japan 16 447 1.0× 117 0.3× 184 1.0× 255 1.7× 314 2.5× 65 1.1k
Weipeng Zhao China 16 160 0.4× 379 1.0× 501 2.7× 36 0.2× 226 1.8× 67 1.1k
Takuya Ishikawa Japan 17 70 0.2× 262 0.7× 257 1.4× 246 1.7× 132 1.0× 39 966
Lingling Du United States 18 424 0.9× 335 0.9× 567 3.0× 65 0.4× 855 6.8× 46 1.6k
Raffaella Carletti Italy 16 115 0.3× 113 0.3× 193 1.0× 40 0.3× 121 1.0× 56 702
Adelina Curaj Germany 15 229 0.5× 148 0.4× 231 1.2× 69 0.5× 53 0.4× 30 756

Countries citing papers authored by Lars Michel

Since Specialization
Citations

This map shows the geographic impact of Lars Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Michel more than expected).

Fields of papers citing papers by Lars Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Michel. The network helps show where Lars Michel may publish in the future.

Co-authorship network of co-authors of Lars Michel

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Michel. A scholar is included among the top collaborators of Lars Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Michel. Lars Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Παπαθανασίου, Μαρία, Lars Michel, Tienush Rassaf, et al.. (2025). Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival. Annals of Hematology. 104(3). 1777–1788. 1 indexed citations
2.
Michel, Lars, Péter Ferdinandy, & Tienush Rassaf. (2024). Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac Dysfunction. Current Heart Failure Reports. 21(3). 214–223. 2 indexed citations
3.
Mincu, Raluca, Julia Vogel, Karin Klingel, et al.. (2024). Cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy – A real-world observational study. IJC Heart & Vasculature. 56. 101581–101581. 1 indexed citations
4.
Settelmeier, Stephan, Zohreh Varasteh, Amir A. Mahabadi, et al.. (2024). FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice. JACC. Cardiovascular imaging. 17(7). 811–823. 3 indexed citations
5.
Michel, Lars, et al.. (2024). (Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac Amyloidosis. Current Heart Failure Reports. 21(3). 224–237. 3 indexed citations
6.
Korste, Sebastian, Stephan Settelmeier, Lars Michel, et al.. (2023). Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart. International Journal of Molecular Sciences. 24(7). 6052–6052. 4 indexed citations
7.
Mincu, Raluca, et al.. (2023). Gender differences in cardio-oncology care of patients treated with immune checkpoint inhibitor therapy. European Heart Journal. 44(Supplement_2). 1 indexed citations
8.
Mincu, Raluca, Sebastian Korste, Lars Michel, et al.. (2023). High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy. Clinical Research in Cardiology. 113(2). 301–312. 13 indexed citations
9.
Pohl, Julia, Matthias Totzeck, Lars Michel, et al.. (2022). Right Ventricular and Atrial Strain in Patients with Advanced Melanoma Undergoing Immune Checkpoint Inhibitor Therapy. ESC Heart Failure. 9(5). 3533–3542. 4 indexed citations
10.
Michel, Lars, Dirk Schadendorf, & Tienush Rassaf. (2020). Oncocardiology: new challenges, new opportunities. Herz. 45(7). 619–625. 12 indexed citations
11.
Michel, Lars, Matthias Totzeck, Lorenz Lehmann, & Daniel Finke. (2020). Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system. Herz. 45(7). 645–651. 10 indexed citations
12.
Mrotzek, Simone M., Alessia Lena, Sara Hadzibegovic, et al.. (2020). Assessment of coronary artery disease during hospitalization for cancer treatment. Clinical Research in Cardiology. 110(2). 200–210. 13 indexed citations
13.
Michel, Lars, Raluca Mincu, Simone M. Mrotzek, et al.. (2020). Cardiac Biomarkers for the Detection of Cardiotoxicity in Childhood Cancer—A Meta-Analysis. ESC Heart Failure. 7(2). 423–433. 29 indexed citations
14.
Merz, Simon F., Sebastian Korste, Lea Bornemann, et al.. (2019). Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and response. Nature Communications. 10(1). 2312–2312. 54 indexed citations
15.
Schlüter, A, Lars Michel, Salvador J. Díaz‐Cano, et al.. (2019). Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor. Thyroid. 29(9). 1286–1301. 15 indexed citations
16.
Michel, Lars, Tienush Rassaf, & Matthias Totzeck. (2019). Cardiotoxicity from immune checkpoint inhibitors. IJC Heart & Vasculature. 25. 100420–100420. 87 indexed citations
17.
Michel, Lars, Raluca Mincu, Amir A. Mahabadi, et al.. (2019). Troponins and Brain Natriuretic Peptides for the Prediction of Cardiotoxicity in Cancer Patients: A Meta-Analysis. European Journal of Heart Failure. 22(2). 350–361. 165 indexed citations
18.
Botezatu, Lacramioara, Lars Michel, Charles Vadnais, et al.. (2016). Epigenetic therapy as a novel approach for GFI136N-associated murine/human AML. Experimental Hematology. 44(8). 713–726.e14. 12 indexed citations
19.
Botezatu, Lacramioara, Lars Michel, Christian Thiede, et al.. (2014). Gfi1 as a new target and predictive marker in AML. Experimental Hematology. 42(8). S20–S20. 1 indexed citations
20.
Seidl, Stefan, Lars Michel, Katja Specht, et al.. (2010). ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non–Small Cell Lung Cancer. Cancer Research. 70(13). 5368–5378. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie G. Lenneman Breakdown of academic impact, for papers by Nesreen S. Ismail Breakdown of academic impact, for papers by Christopher Kane Breakdown of academic impact, for papers by Denise Traxler Breakdown of academic impact, for papers by Takahiro Nishida Breakdown of academic impact, for papers by Weipeng Zhao Breakdown of academic impact, for papers by Takuya Ishikawa Breakdown of academic impact, for papers by Lingling Du Breakdown of academic impact, for papers by Raffaella Carletti Breakdown of academic impact, for papers by Adelina Curaj
Rankless by CCL
2026